1071974-01-0

Basic information

• Product Name: Benzyl 2-cyano-2-(4-fluoro-5-Methyl-2-nitrophenyl)acetate
• Synonyms: Benzyl 2-cyano-2-(4-fluoro-5-Methyl-2-nitrophenyl)acetate
• CAS NO: 1071974-01-0
• Molecular Formula: C₁₇H₁₃FN₂O₄
• Molecular Weight: 328.2945232
• Mol File: 1071974-01-0.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: Benzyl 2-cyano-2-(4-fluoro-5-Methyl-2-nitrophenyl)acetate(CAS DataBase Reference)
• NIST Chemistry Reference: Benzyl 2-cyano-2-(4-fluoro-5-Methyl-2-nitrophenyl)acetate(1071974-01-0)
• EPA Substance Registry System: Benzyl 2-cyano-2-(4-fluoro-5-Methyl-2-nitrophenyl)acetate(1071974-01-0)

Safety Data

• Hazardous Substances Data: 1071974-01-0(Hazardous Substances Data)

Usage

General Description

Benzyl 2-cyano-2-(4-fluoro-5-methyl-2-nitrophenyl)acetate is a chemical compound with the molecular formula C18H15FN2O4. It is an ester derivative of the compound 2-cyano-2-(4-fluoro-5-methyl-2-nitrophenyl)acetic acid, and it is commonly used in organic synthesis and pharmaceutical research. The compound is a yellow solid at room temperature and is moderately soluble in organic solvents. It is known to have potential biological activities and is used as a reagent in the synthesis of various pharmaceutical compounds. Additionally, it is important to handle this compound with caution, as it may have hazardous effects if not handled properly.

Upstream product

• 14447-18-8 benzyl 2-cyanoacetate 
• 141412-60-4 1,4-difluoro-2-methyl-5-nitrobenzene 

Downstream Products

• 162100-95-0 6-fluoro-5-methyl-1H-indole 

Relevant articles and documents

(AZA)INDOLE DERIVATIVE AND USE THEREOF FOR MEDICAL PURPOSES

The present invention provides compounds useful as agents for the prevention or treatment of a disease associated with abnormal serum uric acid level which has a uricosuric activity or the like. The present invention relates to (aza)indole derivatives represented by the following general formula (I) having xanthine oxidase inhibitory activities and useful as agents for the prevention or treatment of a disease associated with abnormality of serum uric acid level, prodrugs thereof, or salts thereof. In the formula (I), T represents nitro or cyano and the like; ring J represents aryl or heteroaryl and the like; Q represents carboxy or 5-tetazolyl and the like; Y represents H, OH, NH2, halogen, nitro, alkyl, alkoxy and the like; X1, X2 and X3 independently represent CR2 or N; R1 and R2 independently represent halogen, cyano, haloalkyl, A-D-E-G, -N(-D-E-G)2 and the like, in the formula, A represents a single bond, O, S and the like; D and G independently represent optionally substituted alkylene, cycloalkylene, heterocycloalkylene, arylene, heteroarylene and the like; E represents a single bond, O, S, COO, SO2 and the like.